Origin Life Sciences, Inc. (OLSI)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	78.97M
Revenue (ttm)	n/a
Net Income (ttm)	-8.84M
Shares Out	19.74M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About OLSI

Origin Life Sciences is a clinical-stage biotechnology company that has been developing a proprietary patented high-energy plasma device that generates nitric oxide (“NO”) in the form of a plasma/NO stream and delivers it to targeted locations of the body. The stream can potentially be used for various therapeutic purposes, including as an anti-infective, anti-inflammatory and tissue-regenerative therapy for chronic wounds and skin and soft tissue infections. The U.S. Food and Drug Administration previously determined that our product will be a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 7
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: OLSI
• Website: https://www.originww.com/